Government news, all in one place

Medicines and Healthcare products Regulatory Agency

782 articles

Showing 91-120

If you take a GLP 1 medicine and have been hospitalised by acute pancreatitis, the Yellow Card Biobank wants to hear from you 

If you take a GLP 1 medicine and have been hospitalised by acute pancreatitis, the Yellow Card Biobank wants to hear from you 

Thursday, 26 June 2025

GLP-1 medicines are licensed for Type 2 diabetes and weight management, and include the branded products Ozempic, Mounjaro and Wegovy  ...

Read More → press_release
MHRA seizes 7.7 million doses of illegal medicines and removes hundreds of illegal online listings as part of Operation Pangea

MHRA seizes 7.7 million doses of illegal medicines and removes hundreds of illegal online listings as part of Operation Pangea

Wednesday, 25 June 2025

Operation Pangea brings together health regulators, customs authorities, law enforcement agencies, and private sector partners to tackle the threat po...

Read More → press_release
MHRA publishes final Business Plan for 2023 2026 Corporate Plan 

MHRA publishes final Business Plan for 2023 2026 Corporate Plan 

Wednesday, 25 June 2025

The new Business Plan sets out priorities for 2025–26: Protecting public safety and maintaining public trust; delivering efficient, predictable servic...

Read More → news_story
UK MHRA leads safe use of AI in healthcare as first country in new global network

UK MHRA leads safe use of AI in healthcare as first country in new global network

Monday, 23 June 2025

The MHRA will help shape international rules for AI in healthcare – speeding up access to safe, effective technologies into the NHS and worldwide....

Read More → press_release
AI breakthroughs drive expansion of ‘Airlock’ testing programme to support AI powered healthcare innovation

AI breakthroughs drive expansion of ‘Airlock’ testing programme to support AI powered healthcare innovation

Monday, 23 June 2025

MHRA opens second round of applications to test cutting-edge AI medical technologies following successful pilot phase....

Read More → press_release
MHRA approves UK’s first anti PD 1 monoclonal antibody for treatment of aggressive form of lung cancer

MHRA approves UK’s first anti PD 1 monoclonal antibody for treatment of aggressive form of lung cancer

Friday, 20 June 2025

As with all products, we will keep its safety under close review...

Read More → press_release
Fast, Expert and Open – how the MHRA is poised to become a global leader in risk proportionate regulation

Fast, Expert and Open – how the MHRA is poised to become a global leader in risk proportionate regulation

Wednesday, 18 June 2025

New MHRA CEO puts safety, accelerated access and innovation at the centre of agency’s refreshed strategic direction....

Read More → press_release
First major overhaul of medical device regulation comes into force across Great Britain

First major overhaul of medical device regulation comes into force across Great Britain

Monday, 16 June 2025

New Post-Market Surveillance (PMS) regulations have taken effect across Great Britain, requiring medical device manufacturers to proactively monitor t...

Read More → press_release
Chikungunya vaccine (IXCHIQ) temporarily paused in people aged 65 and over as precautionary measure

Chikungunya vaccine (IXCHIQ) temporarily paused in people aged 65 and over as precautionary measure

Monday, 09 June 2025

This is a precautionary measure while the MHRA conducts the safety review. ...

Read More → news_story
MHRA launches new digital hub in Leeds to drive innovation and regional growth

MHRA launches new digital hub in Leeds to drive innovation and regional growth

Friday, 06 June 2025

The new hub will strengthen the MHRA’s work with regional partners and boost the UK’s digital health and life sciences sector....

Read More → press_release
Helping bring phage medicines to UK patients – guidance for industry

Helping bring phage medicines to UK patients – guidance for industry

Thursday, 05 June 2025

Bacteriophages – viruses that selectively fight bacteria – may offer new hope in fighting infections and tackling antimicrobial resistance....

Read More → press_release
Women on “skinny jabs” must use effective contraception, MHRA urges in latest guidance 

Women on “skinny jabs” must use effective contraception, MHRA urges in latest guidance 

Wednesday, 04 June 2025

Anyone who suspects that they’ve had an adverse reaction to their weight loss or diabetes medicine or suspects it is not a genuine product, should rep...

Read More → press_release
MHRA approves aumolertinib to treat non small cell lung cancer

MHRA approves aumolertinib to treat non small cell lung cancer

Monday, 02 June 2025

As with all products, we will keep its safety under close review...

Read More → press_release
MHRA approves polihexanide to treat acanthamoeba keratitis

MHRA approves polihexanide to treat acanthamoeba keratitis

Thursday, 22 May 2025

As with any medicine, the MHRA will keep the safety and effectiveness of polihexanide under close review.? ...

Read More → news_story
First MHRA Board meeting held in Scotland, underlining agency’s commitment to regional health equality and growth

First MHRA Board meeting held in Scotland, underlining agency’s commitment to regional health equality and growth

Wednesday, 21 May 2025

The meeting, which took place at the Royal College of Surgeons in Edinburgh, centred on the MHRA’s commitment to delivering the agency’s priorities in...

Read More → press_release
Building a faster, more effective clinical trials system

Building a faster, more effective clinical trials system

Monday, 19 May 2025

By MHRA Chief Executive Lawrence Tallon...

Read More → news_story
MHRA highlights “remarkable” progress and launches real world data consultation on International Clinical Trials Day

MHRA highlights “remarkable” progress and launches real world data consultation on International Clinical Trials Day

Monday, 19 May 2025

“…the MHRA is once again taking a global lead” says Lord O’Shaughnessy...

Read More → press_release
MHRA approves guselkumab for Crohn’s disease and ulcerative colitis

MHRA approves guselkumab for Crohn’s disease and ulcerative colitis

Monday, 19 May 2025

As with all products, we will keep its safety under close review...

Read More → press_release
MHRA approves vaccine to protect against pneumococcal infections such as pneumonia and meningitis

MHRA approves vaccine to protect against pneumococcal infections such as pneumonia and meningitis

Thursday, 15 May 2025

As with all products, the MHRA will keep its safety under close review....

Read More → news_story
Meet the women helping ensure that digital mental health technologies are safe, effective and developed considering the needs of the people who use them

Meet the women helping ensure that digital mental health technologies are safe, effective and developed considering the needs of the people who use them

Monday, 12 May 2025

Mental health apps are everywhere, offering everything from mood tracking to therapy. But with so many options, how can people tell what these tools a...

Read More → news_story
MHRA approves first UK treatment for congenital thrombotic thrombocytopenic purpura (cTTP) 

MHRA approves first UK treatment for congenital thrombotic thrombocytopenic purpura (cTTP) 

Monday, 12 May 2025

As with all products, the MHRA will keep its safety under close review....

Read More → news_story
MHRA approves world’s first low carbon version of COPD inhaler Trixeo Aerosphere

MHRA approves world’s first low carbon version of COPD inhaler Trixeo Aerosphere

Monday, 12 May 2025

As with all medicines, the MHRA will continue to monitor the safety and effectiveness of Trixeo Aerosphere...

Read More → press_release
MHRA approves teprotumumab as the first UK treatment for adults with moderate to severe Thyroid Eye Disease (TED)

MHRA approves teprotumumab as the first UK treatment for adults with moderate to severe Thyroid Eye Disease (TED)

Tuesday, 06 May 2025

As with all products, the MHRA will keep its safety under close review....

Read More → press_release
Vimkunya vaccine approved to prevent disease caused by the chikungunya virus in people 12 years of age and older 

Vimkunya vaccine approved to prevent disease caused by the chikungunya virus in people 12 years of age and older 

Thursday, 01 May 2025

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (1 May 2025) approved a vaccine (Vimkunya) used to prevent disease caused by ...

Read More → news_story
MHRA authorises cancer treatment variation with an administration time of 3–5 minutes

MHRA authorises cancer treatment variation with an administration time of 3–5 minutes

Wednesday, 30 April 2025

As with all products, the MHRA will keep its safety under close review....

Read More → press_release
Twelve arrested in MHRA’s biggest ever crackdown on organised medicines trafficking

Twelve arrested in MHRA’s biggest ever crackdown on organised medicines trafficking

Monday, 28 April 2025

Dawn raids in four counties across the West Midlands and the Northwest of England this morning (29 April) dismantle major criminal network trafficking...

Read More → press_release
Acoramidis approved to treat wild type or variant transthyretin amyloidosis in adults with cardiomyopathy

Acoramidis approved to treat wild type or variant transthyretin amyloidosis in adults with cardiomyopathy

Friday, 25 April 2025

As with all products, the MHRA will keep its safety under close review....

Read More → press_release
Obecabtagene autoleucel conditionally approved to treat adults with relapsed or refractory B cell precursor acute lymphoblastic leukaemia

Obecabtagene autoleucel conditionally approved to treat adults with relapsed or refractory B cell precursor acute lymphoblastic leukaemia

Thursday, 24 April 2025

As with all products, the MHRA will keep its safety under close review....

Read More → press_release
Patients with asthma reminded of the increased risk of severe asthma attacks from overusing blue inhalers

Patients with asthma reminded of the increased risk of severe asthma attacks from overusing blue inhalers

Thursday, 24 April 2025

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding patients with asthma of the importance of using their preventer (anti-infl...

Read More → press_release
MHRA approves first UK treatment for Friedreich’s ataxia, omaveloxolone

MHRA approves first UK treatment for Friedreich’s ataxia, omaveloxolone

Wednesday, 23 April 2025

As with all products, we will keep its safety under close review....

Read More → press_release

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: